MAY 11, 2016 1:30 PM PDT

Precision Medicine - Moving From Pilot To Production Deployment

Speakers
  • Chief Executive Officer, Genospace
    Biography
      Mick's 15+ year career has tracked the path of genomics from basic research to clinical care. Over this time he has held leadership positions in academia and industry, and has developed informatics solutions for pharma/biotech R&D, ag-bio, and academic, government, and community healthcare providers. Prior to launching Genospace, he and partner John Quackenbush established the Center for Cancer Computational Biology at the Dana-Farber Cancer Institute. Mick began his career at Lion Bioscience Research Inc. and UK-based informatics provider InforSense.

      Mick earned a BS in computer science and a BA in molecular biology from the University of Colorado at Boulder.

    Abstract:

    The clinical utility of high-dimensional molecular profiling has been provisionally established in several domains of medicine.  Today, interrogation of scores of genes and even whole exomes and genomes is an increasingly common practice that is informing diagnostic, theranostic, reproductive and other decisions by patients and physicians. Progress has been substantial, but vast potential remains untapped.
     
    As seen in biological research, genomic profiling technologies will proliferate in the clinic, providing insight across a myriad of molecular actors, processes, tissues and time points.  Indeed laboratory medicine is evolving from a bench science to an information science.
     
    One key objective of this presentation is to identify common challenges and roadblocks faced in deploying precision medicine programs at scale: Integrating the numerous complex and fragmented data sources necessary to inform clinical reporting; structuring biomarker and other association details such that they can be appropriately matched to observed events; and meeting the performance requirements necessary to support highly interconnected operational clinical systems necessary at high volumes. Here we will present specific technical solutions that can help move these programs from pilot to full production deployment.
     
    Beyond the immediate clinical utility, a remarkable aspect of precision medicine is the ability to apply aggregated data sets for a whole host of applications across the spectrum of research, development and clinical care.
     
    The second objective will be to explore examples of these myriad additional uses, and to discuss how a new breed of technical capabilities can provide the data agility necessary to maximize the value of these data assets.
     
    Finally, we will explore why molecular medicine is an ideal proving ground for the data agility the entire healthcare system so urgently needs.


    Show Resources
    You May Also Like
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    FEB 19, 2020 11:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    Loading Comments...
    Show Resources